Japanese (NIKKEI) Drug Retail Industry Analysis
UpdatedMay 21, 2022
DataAggregated Company Financials
Companies21
- 7D1.3%
- 3M-14.4%
- 1Y-24.3%
- YTD-20.9%
In the last week, the Drug Retail industry is up 1.3%, with MatsukiyoCocokara up 9.5%. During this same period, the SundrugLtd underperformed, falling 6.5%. In contrast, the industry has lost 24% in the last 12 months. Earnings are forecast to grow by 7.6% annually.
Industry Valuation and Performance
Has the Japanese Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Sat, 21 May 2022 | JP¥3.4t | JP¥7.0t | JP¥205.9b | 13.1x |
| Mon, 18 Apr 2022 | JP¥3.6t | JP¥6.9t | JP¥202.7b | 14.7x |
| Wed, 16 Mar 2022 | JP¥4.0t | JP¥6.9t | JP¥206.0b | 16x |
| Fri, 11 Feb 2022 | JP¥3.9t | JP¥6.8t | JP¥194.1b | 16.1x |
| Sun, 09 Jan 2022 | JP¥4.2t | JP¥6.7t | JP¥197.8b | 15.3x |
| Tue, 07 Dec 2021 | JP¥4.4t | JP¥6.7t | JP¥200.8b | 14.6x |
| Thu, 04 Nov 2021 | JP¥5.2t | JP¥7.1t | JP¥206.1b | 16.2x |
| Sat, 02 Oct 2021 | JP¥4.9t | JP¥7.0t | JP¥209.6b | 16.5x |
| Mon, 30 Aug 2021 | JP¥5.1t | JP¥7.0t | JP¥212.7b | 17.3x |
| Tue, 06 Jul 2021 | JP¥4.7t | JP¥7.0t | JP¥212.3b | 16.7x |
| Fri, 09 Apr 2021 | JP¥5.0t | JP¥7.0t | JP¥217.6b | 17.7x |
| Thu, 31 Dec 2020 | JP¥4.9t | JP¥6.9t | JP¥225.1b | 18.9x |
| Sun, 04 Oct 2020 | JP¥5.0t | JP¥6.8t | JP¥212.6b | 19.8x |
| Wed, 08 Jul 2020 | JP¥4.8t | JP¥6.7t | JP¥205.8b | 18.7x |
| Tue, 31 Mar 2020 | JP¥4.3t | JP¥6.6t | JP¥202.9b | 16.3x |
| Fri, 03 Jan 2020 | JP¥4.2t | JP¥6.5t | JP¥192.4b | 18.4x |
| Mon, 07 Oct 2019 | JP¥3.8t | JP¥6.4t | JP¥195.3b | 18.3x |
| Sun, 30 Jun 2019 | JP¥3.3t | JP¥6.2t | JP¥187.2b | 18.9x |
Median PE Ratio
17x
Current Industry PE
- Investors are more pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 13.1x which is lower than its 3-year average PE of 17.5x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have grown 3.3% per year over the last three years.
- Revenues for these companies have grown 4.1% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Japanese Drug Retail compare with similar industries?
| JP Market | 0.71% | |
| Consumer Staples | -2.28% | |
| Food and Staples Retail | -3.47% | |
| Drug Retail | 1.27% | |
| Food Distributors | 0.23% | |
| Big Box Super Stores | -4.47% | |
| Food Retail | -5.43% | |
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 3088 MatsukiyoCocokara | JP¥4.67k | 9.5% +JP¥57.2b | 6.4% | PS19.1x | |
| 3391 Tsuruha Holdings | JP¥6.80k | 2.1% +JP¥6.8b | -48.5% | PS14.6x | |
| 3034 Qol Holdings | JP¥1.20k | 15.0% +JP¥5.8b | -20.0% | PS8.1x | |
| 7649 Sugi HoldingsLtd | JP¥5.26k | 1.5% +JP¥4.9b | -39.7% | PS16.8x | |
| 3549 Kusuri No Aoki Holdings | JP¥5.53k | 1.7% +JP¥2.8b | -29.8% | PS17.9x |